Posts in tag
EMA
Regulator investigates Ozempic suicidal ideation link
Novo Nordisk’s diabetes medication, Ozempic (semaglutide) and weight-loss treatment Saxenda (liraglutide) are being investigated, following reports they may be associated with suicidal ideation The European Medicines Agency (EMA) is looking …
Semaglutide cancer and depression risks investigation
Concerns Ozempic ingredient may be related to thyroid cancer and suicide ideation draws attention of EMA Semaglutide, the active ingredient in hyped diabetes and weight loss drug, Ozempic and others, …